nasdaq:cori
|
89022
|
May 5th, 2024 12:00AM
|
Corium
|
8.3K
|
460.00
|
Open
|
|
May 4th, 2024 11:13PM
|
May 4th, 2024 11:13PM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
May 4th, 2024 12:00AM
|
Corium
|
8.3K
|
460.00
|
Open
|
|
May 3rd, 2024 10:53PM
|
May 4th, 2024 06:33PM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
May 3rd, 2024 12:00AM
|
Corium
|
8.3K
|
461.00
|
Open
|
|
May 2nd, 2024 10:48PM
|
May 3rd, 2024 02:18PM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
May 2nd, 2024 12:00AM
|
Corium
|
8.3K
|
461.00
|
Open
|
|
May 1st, 2024 10:57PM
|
May 2nd, 2024 09:54AM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
May 1st, 2024 12:00AM
|
Corium
|
8.3K
|
463.00
|
Open
|
|
Apr 30th, 2024 11:49PM
|
May 1st, 2024 09:20AM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
Apr 30th, 2024 12:00AM
|
Corium
|
8.3K
|
464.00
|
Open
|
|
Apr 29th, 2024 11:15PM
|
Apr 30th, 2024 08:12AM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
Apr 29th, 2024 12:00AM
|
Corium
|
8.3K
|
464.00
|
Open
|
|
Apr 28th, 2024 11:39PM
|
Apr 29th, 2024 09:20AM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
Apr 28th, 2024 12:00AM
|
Corium
|
8.3K
|
463.00
|
Open
|
|
Apr 27th, 2024 11:10PM
|
Apr 27th, 2024 11:10PM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
Apr 27th, 2024 12:00AM
|
Corium
|
8.3K
|
464.00
|
Open
|
|
Apr 26th, 2024 10:50PM
|
Apr 26th, 2024 10:50PM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:cori
|
89022
|
Apr 26th, 2024 12:00AM
|
Corium
|
8.3K
|
464.00
|
Open
|
|
Apr 25th, 2024 10:57PM
|
Apr 26th, 2024 08:16AM
|
Corium is a commercial-stage biopharmaceutical company that is leading the development and commercialization of central nervous system (CNS) healthcare therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.
Collaborating with some of the world's largest pharmaceutical and consumer product companies, we have a track record and depth of experience in taking products from concept, through development, to manufacturing and final commercialization.
|
Open
|
|
Open
|
11 Farnsworth Street
|
Boston
|
MA
|
US
|
02210
|
|
Corium
|
Health Care
|
Pharmaceuticals & Biotechnology
|